Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5.14M | $53.0M | -- | -- | 2026-03-31 |
| Sanofi | 2.78M | $29.0M | -- | -- | 2026-03-31 |
| Cormorant Asset Management, LP | 2.47M | $25.0M | -- | -- | 2026-03-31 |
| TCG Crossover Management, LLC | 2.05M | $21.0M | -- | -- | 2026-03-31 |
| FEDERATED HERMES, INC. | 1.62M | $16.0M | -- | -- | 2026-03-31 |
| Casdin Capital, LLC | 1.55M | $16.0M | -- | -- | 2026-03-31 |
| ANDERA PARTNERS | 1.54M | $16.0M | -- | -- | 2026-03-31 |
| FMR LLC | 1.46M | $15.0M | -- | -- | 2026-03-31 |
| Nantahala Capital Management, LLC | 1.20M | $12.0M | -- | -- | 2026-03-31 |
| Aberdeen Group plc | 707.7K | $7.0M | -- | -- | 2026-03-31 |
